$BMY Recent News Earnings roundup: Cubist, Mer
Post# of 44846
Posted On: 05/02/2014 9:38:45 AM
$BMY Recent News
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 11:48 a.m. April 29, 2014 - Russ Britt
Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. April 29, 2014 - William L. Watts
Twitter, eBay, Sprint, Herbalife are stocks to watch 5:31 a.m. April 29, 2014 - Sue Chang
Market leaders energy, utilities face earnings gauntlet 11:17 a.m. April 28, 2014 - Wallace Witkowski
The market in a minute: Sell calls and puts 11:11 a.m. April 28, 2014 - The Trading Deck
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard 5:01 p.m. May 1, 2014 - TheStreet.com
Bristol-Myers Squibb's (BMY) CEO John Elicker on Q1 2014 Earnings - Call Transcript 12:26 p.m. April 30, 2014 - TheStreet.com
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala 10:37 a.m. April 30, 2014 - Seeking Alpha
6 Drugs That Could Move the Pharma Market 9:24 a.m. April 30, 2014 - Wall St. Cheat Sheet
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com
Bristol-Myers Squibb's CEO Discusses Q1 2014 Results - Earnings Call Transcript 3:04 p.m. April 29, 2014 - Seeking Alpha
Bristol-Myers Reports Higher Earnings, Biotech Buy 2:07 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Why Bristol-Myers Squibb (BMY) Stock Is Down Today 12:44 p.m. April 29, 2014 - TheStreet.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
6 Drugs That Could Move the Market 9:58 a.m. April 29, 2014 - Wall St. Cheat Sheet
10-Q: BRISTOL MYERS SQUIBB CO 9:51 a.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Bristol-Myers Squibb Company (BMY) Is Today's Pre-Market Laggard Stock 9:39 a.m. April 29, 2014 - TheStreet.com
Top 5 Responsible Corporations in the U.S. 9:22 a.m. April 29, 2014 - Wall St. Cheat Sheet
Bristol-Myers Squibb Company Discusses Q1 2014 Results (Webcast) 8:55 a.m. April 29, 2014 - Seeking Alpha
More on Bristol-Myers Q1: Buys iPierian for $175M up front 8:44 a.m. April 29, 2014 - Seeking Alpha
UPDATE: Bristol-Myers Posts Higher Q1 Profit 7:44 a.m. April 29, 2014 - benzinga.com
Bristol-Myers Squibb Acquires iPierian for $175M, Potential Milestone Payments of $550M 6:08 a.m. April 29, 2014 - benzinga.com
'Fast Money' Recap: The Problem With Growth Stocks 5:00 a.m. April 29, 2014 - TheStreet.com
AstraZeneca Chief Puts Cancer Drugs Ahead of Deals 9:12 p.m. April 28, 2014 - The Wall Street Journal Interactive Edition
Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie 8:00 a.m. Today - PR Newswire - PRF
Technical Recap on Pharma Equities -- Research on Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline 9:16 a.m. May 1, 2014 - PR Newswire - PRF
Philanthropic Leaders Pledge $170 Million to Support Veterans and Military Families 11:11 a.m. April 30, 2014 - GlobeNewswire
Are Exosomes the Next PD-1 in Cancer Research? 10:01 a.m. April 30, 2014 - ACCESSWIRE
Kimberly-Clark Ranks Among Top 20 on '100 Best Corporate Citizens' Survey For Sixth Straight Year 4:35 p.m. April 29, 2014 - PR Newswire - PRF
North America Contrast Media Injectors Market Outlook to 2020 11:51 a.m. April 29, 2014 - PR Newswire - PRF
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 3:10 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List 1:01 p.m. April 24, 2014 - BusinessWire - BZX
Allied Minds Names Peter Dolan and Jeff Rohr to Board of Directors 8:04 a.m. April 24, 2014 - BusinessWire - BZX
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013 4:55 p.m. April 23, 2014 - PR Newswire - PRF
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
North America Nuclear Imaging Equipment Market Outlook to 2020 12:48 p.m. April 23, 2014 - PR Newswire - PRF
North America Ultrasound Systems Market Outlook to 2020 12:36 p.m. April 23, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy(R)) in Advanced Melanoma 7:30 a.m. April 23, 2014 - Marketwire
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement 7:00 p.m. April 22, 2014 - BusinessWire - BZX
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE 11:30 a.m. April 17, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 7:27 a.m. April 14, 2014 - Marketwire
Earnings roundup: Cubist, Merck gain as HCA, Bristol-Myers slide 11:48 a.m. April 29, 2014 - Russ Britt
Value trumps growth as investors pick Exxon over Tesla 10:48 a.m. April 29, 2014 - William L. Watts
Twitter, eBay, Sprint, Herbalife are stocks to watch 5:31 a.m. April 29, 2014 - Sue Chang
Market leaders energy, utilities face earnings gauntlet 11:17 a.m. April 28, 2014 - Wallace Witkowski
The market in a minute: Sell calls and puts 11:11 a.m. April 28, 2014 - The Trading Deck
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen
Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Laggard 5:01 p.m. May 1, 2014 - TheStreet.com
Bristol-Myers Squibb's (BMY) CEO John Elicker on Q1 2014 Earnings - Call Transcript 12:26 p.m. April 30, 2014 - TheStreet.com
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala 10:37 a.m. April 30, 2014 - Seeking Alpha
6 Drugs That Could Move the Pharma Market 9:24 a.m. April 30, 2014 - Wall St. Cheat Sheet
Celgene Deal Chief Calls Big Pharma Gutless For Lack of Biotech M&A 4:26 p.m. April 29, 2014 - TheStreet.com
Bristol-Myers Squibb's CEO Discusses Q1 2014 Results - Earnings Call Transcript 3:04 p.m. April 29, 2014 - Seeking Alpha
Bristol-Myers Reports Higher Earnings, Biotech Buy 2:07 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Why Bristol-Myers Squibb (BMY) Stock Is Down Today 12:44 p.m. April 29, 2014 - TheStreet.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
6 Drugs That Could Move the Market 9:58 a.m. April 29, 2014 - Wall St. Cheat Sheet
10-Q: BRISTOL MYERS SQUIBB CO 9:51 a.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Bristol-Myers Squibb Company (BMY) Is Today's Pre-Market Laggard Stock 9:39 a.m. April 29, 2014 - TheStreet.com
Top 5 Responsible Corporations in the U.S. 9:22 a.m. April 29, 2014 - Wall St. Cheat Sheet
Bristol-Myers Squibb Company Discusses Q1 2014 Results (Webcast) 8:55 a.m. April 29, 2014 - Seeking Alpha
More on Bristol-Myers Q1: Buys iPierian for $175M up front 8:44 a.m. April 29, 2014 - Seeking Alpha
UPDATE: Bristol-Myers Posts Higher Q1 Profit 7:44 a.m. April 29, 2014 - benzinga.com
Bristol-Myers Squibb Acquires iPierian for $175M, Potential Milestone Payments of $550M 6:08 a.m. April 29, 2014 - benzinga.com
'Fast Money' Recap: The Problem With Growth Stocks 5:00 a.m. April 29, 2014 - TheStreet.com
AstraZeneca Chief Puts Cancer Drugs Ahead of Deals 9:12 p.m. April 28, 2014 - The Wall Street Journal Interactive Edition
Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie 8:00 a.m. Today - PR Newswire - PRF
Technical Recap on Pharma Equities -- Research on Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline 9:16 a.m. May 1, 2014 - PR Newswire - PRF
Philanthropic Leaders Pledge $170 Million to Support Veterans and Military Families 11:11 a.m. April 30, 2014 - GlobeNewswire
Are Exosomes the Next PD-1 in Cancer Research? 10:01 a.m. April 30, 2014 - ACCESSWIRE
Kimberly-Clark Ranks Among Top 20 on '100 Best Corporate Citizens' Survey For Sixth Straight Year 4:35 p.m. April 29, 2014 - PR Newswire - PRF
North America Contrast Media Injectors Market Outlook to 2020 11:51 a.m. April 29, 2014 - PR Newswire - PRF
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 3:10 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List 1:01 p.m. April 24, 2014 - BusinessWire - BZX
Allied Minds Names Peter Dolan and Jeff Rohr to Board of Directors 8:04 a.m. April 24, 2014 - BusinessWire - BZX
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013 4:55 p.m. April 23, 2014 - PR Newswire - PRF
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
North America Nuclear Imaging Equipment Market Outlook to 2020 12:48 p.m. April 23, 2014 - PR Newswire - PRF
North America Ultrasound Systems Market Outlook to 2020 12:36 p.m. April 23, 2014 - PR Newswire - PRF
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy(R)) in Advanced Melanoma 7:30 a.m. April 23, 2014 - Marketwire
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement 7:00 p.m. April 22, 2014 - BusinessWire - BZX
Surveyed U.S. Physicians Expect Strong Uptake of Novel Oral Anticoagulants for the Treatment of VTE 11:30 a.m. April 17, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 7:27 a.m. April 14, 2014 - Marketwire
(0)
(0)Scroll down for more posts ▼